Business Description
Numinus Wellness Inc
NAICS : 621399
SIC : 8613
ISIN : CA67054W1032
Share Class Description:
FRA:LR23: Ordinary SharesCompare
Compare
Traded in other countries / regions
NUMI.CanadaNUMIF.USALR23.Germany IPO Date
2011-02-02Description
Numinus Wellness Inc develops proprietary, psychedelic-centered, therapeutic products and services through its laboratory and research & development processes. The company's clinic network consists of Numinus Health, Mindspace Services, and the Neurology Center of Toronto. Its services include Ketamine-assisted psychotherapy for depression, neurological care, psychotherapy, and counseling by registered psychologists among others. The company's operating segments are; Clinical research operations, Canadian clinic network, US clinic network and Corporate. The majority of the revenue for the company is generated from US clinic network segment. Geographically, the company has its presence in United States and Canada.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.04 | |||||
| Equity-to-Asset | 0.52 | |||||
| Debt-to-Equity | 0.63 | |||||
| Debt-to-EBITDA | -0.27 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -10.58 | |||||
| Beneish M-Score | -4.23 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 84.6 | |||||
| 3-Year EBITDA Growth Rate | 10.1 | |||||
| 3-Year EPS without NRI Growth Rate | 3.9 | |||||
| 3-Year FCF Growth Rate | -1.6 | |||||
| 3-Year Book Growth Rate | 22.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 30.79 | |||||
| 9-Day RSI | 35.47 | |||||
| 14-Day RSI | 38.58 | |||||
| 6-1 Month Momentum % | -34.02 | |||||
| 12-1 Month Momentum % | -40.41 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.47 | |||||
| Quick Ratio | 2.47 | |||||
| Cash Ratio | 1.52 | |||||
| Days Sales Outstanding | 29.07 | |||||
| Days Payable | 63.77 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -40.6 | |||||
| Shareholder Yield % | -23.15 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 33.28 | |||||
| Operating Margin % | -96.71 | |||||
| Net Margin % | -116.65 | |||||
| FCF Margin % | -74.64 | |||||
| ROE % | -156.5 | |||||
| ROA % | -98.77 | |||||
| ROIC % | -154.68 | |||||
| ROC (Joel Greenblatt) % | -257.48 | |||||
| ROCE % | -114.85 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.85 | |||||
| PB Ratio | 2.42 | |||||
| Price-to-Tangible-Book | 2.38 | |||||
| EV-to-EBIT | -0.9 | |||||
| EV-to-EBITDA | -1.01 | |||||
| EV-to-Revenue | 1.03 | |||||
| EV-to-FCF | -1.38 | |||||
| Earnings Yield (Greenblatt) % | -111.11 | |||||
| FCF Yield % | -71.77 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Numinus Wellness Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 15.736 | ||
| EPS (TTM) (€) | -0.067 | ||
| Beta | 0.47 | ||
| Volatility % | 87.7 | ||
| 14-Day RSI | 38.58 | ||
| 14-Day ATR (€) | 0.004262 | ||
| 20-Day SMA (€) | 0.058645 | ||
| 12-1 Month Momentum % | -40.41 | ||
| 52-Week Range (€) | 0.037 - 0.176 | ||
| Shares Outstanding (Mil) | 320.55 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Numinus Wellness Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Numinus Wellness Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Numinus Wellness Inc Frequently Asked Questions
What is Numinus Wellness Inc(FRA:LR23)'s stock price today?
The current price of FRA:LR23 is €0.05. The 52 week high of FRA:LR23 is €0.18 and 52 week low is €0.04.
When is next earnings date of Numinus Wellness Inc(FRA:LR23)?
The next earnings date of Numinus Wellness Inc(FRA:LR23) is .
Does Numinus Wellness Inc(FRA:LR23) pay dividends? If so, how much?
Numinus Wellness Inc(FRA:LR23) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers